Kiora Pharmaceuticals Inc...

NASDAQ: KPRX · Real-Time Price · USD
2.63
-0.04 (-1.54%)
At close: Aug 20, 2025, 1:36 PM

Kiora Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
3.59M -12.51M -13.58M -16.39M
Depreciation & Amortization
19.2K 62.42K 41.61K 45.3K
Stock-Based Compensation
656.59K 754.94K 462.45K 842.48K
Other Working Capital
2.41M -465.83K 758.79K -725.13K
Other Non-Cash Items
911.27K 3.87M 2.1M 6.17M
Deferred Income Tax
-288.75K 90.32K -113.01K -304.78K
Change in Working Capital
3.67M -1.82M 668.51K -1.04M
Operating Cash Flow
8.56M -9.56M -10.43M -10.68M
Capital Expenditures
-6.26K n/a n/a -63.87K
Cash Acquisitions
n/a n/a 6.38K -93.16K
Purchase of Investments
-35.63M n/a n/a n/a
Sales Maturities Of Investments
12.98M n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-22.66M n/a 6.38K -157.02K
Debt Repayment
n/a n/a n/a -212.28K
Common Stock Repurchased
n/a n/a -15.63K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -187.92K 3.26M 50K
Financial Cash Flow
15.5M 5.97M 8.62M 17.58M
Net Cash Flow
1.34M -3.55M -1.89M 6.67M
Free Cash Flow
8.55M -9.56M -10.43M -10.95M